Rebecca J Ingram Selected Research

Rebecca J Ingram Research Topics

Disease

17	Infections 08/2023 - 06/2009
9	Anthrax 09/2022 - 04/2010
5	Cutaneous anthrax 09/2022 - 04/2010
4	Inflammation (Inflammations) 11/2022 - 01/2018
3	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 09/2017
3	Bacterial Infections (Bacterial Infection) 01/2019 - 04/2010
2	Sepsis (Septicemia) 11/2022 - 06/2009
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2022 - 02/2016
2	Lung Injury 02/2016 - 06/2014
2	Pseudomonas Infections 02/2016 - 01/2012
1	Necrosis 03/2024
1	Persistent Infection 08/2023
1	Pneumonia (Pneumonitis) 11/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Dysbiosis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Acute Lung Injury 06/2014
1	Central Nervous System Diseases (CNS Diseases) 10/2013
1	Wounds and Injuries (Trauma) 07/2012
1	Bacteremia 06/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2009
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2006

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 04/2010
6	EpitopesIBA 09/2022 - 11/2006
6	VaccinesIBA 09/2022 - 11/2006
5	AntigensIBA 09/2022 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
4	CytokinesIBA 11/2022 - 06/2009
4	anthrax toxin (anthrax lethal factor)IBA 09/2022 - 09/2010
3	Anthrax Vaccines (Vaccines, Anthrax)IBA 09/2022 - 04/2010
3	Interleukin-17 (Interleukin 17)IBA 02/2016 - 06/2009
2	InflammasomesIBA 01/2022 - 01/2018
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019 - 01/2012
2	Peptides (Polypeptides)IBA 01/2015 - 05/2014
2	Subunit VaccinesIBA 05/2014 - 09/2010
2	Immunodominant EpitopesIBA 05/2014 - 11/2006
1	Dinoprostone (PGE2)FDA Link 03/2024
1	lipoteichoic acidIBA 11/2022
1	ChemokinesIBA 11/2022
1	edema factorIBA 09/2022
1	ExotoxinsIBA 09/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	cathepsin SIBA 01/2021
1	Cysteine Proteases (Cysteine Protease)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	CuprizoneIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	LactoferrinIBA 12/2018
1	hypothiocyanite ion (OSCN-)IBA 12/2018
1	Interferon Type IIBA 11/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 09/2017
1	ivacaftorIBA 09/2017
1	Antimicrobial PeptidesIBA 09/2017
1	VitaminsIBA 01/2017
1	LipocalinsIBA 01/2017
1	Hepatitis B e AntigensIBA 01/2015
1	Interleukin-5 (Interleukin 5)IBA 01/2015
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 06/2014
1	Fibroblast Growth Factor 7 FDA Link 06/2014
1	AntibodiesIBA 05/2014
1	Heroin (Diamorphine)IBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2013
1	salicylhydroxamic acid (SHAM)IBA 07/2012
1	AminoglycosidesIBA 01/2012
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2010
1	Indicators and Reagents (Reagents)IBA 11/2006

Therapy/Procedure

1	Intraperitoneal Injections 11/2022
1	Therapeutics 09/2017